Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
63 studies found for:    SIDS
Show Display Options
Rank Status Study
21 Recruiting Study of Sleep and Delirium in the Intensive Care Unit (ICU)
Conditions: Delirium;   Sleep Disorders, Circadian Rhythm
Intervention:
22 Recruiting Early Diagnosis and Stem Cell Transplantation for Severe Immunodeficiency Diseases
Condition: Severe Immunodeficiency Diseases
Intervention: Drug: Fludarabine, Busulfan, and Anti-Thymocyte Globulin
23 Not yet recruiting A Study of Subcutaneous Herceptin (Trastuzumab) Administered at Home By Single-Use Injection Device in Patients With Early HER2-Positive Breast Cancer (HOMERUS)
Condition: Breast Cancer
Intervention: Drug: trastuzumab [Herceptin]
24 Completed Assessing the Impact of Smoke-free Legislation on Perinatal Health in the Netherlands
Conditions: Premature Birth;   Perinatal Mortality;   Infant, Low Birth Weight;   Stillbirth;   Infant Mortality;   Sudden Infant Death;   Infant, Very Low Birth Weight;   Infant, Small for Gestational Age
Intervention: Other: Smoke-free legislation
25 Recruiting The Paediatric Virtual Autopsy Trial; Minimally Invasive, Imaging Guided Virtual Autopsy Compared to Conventional Autopsy
Conditions: Stillbirth;   Newborn Death;   Sudden Infant Death
Interventions: Procedure: Minimally invasive, virtual autopsy;   Procedure: Conventional autopsy
26 Recruiting Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional Study
Conditions: Primary Immunodeficiency (PID);   Secondary Immunodeficiency (SID);   Neurological Autoimmune Disease
Intervention: Other: Immunoglobulin G (IgG)
27 Active, not recruiting Re-enforcing Safe Sleep Practices for Caregivers With Tangible Incentives
Condition: Safe Sleep Education
Interventions: Other: Wearable Blanket (Sleep Sack);   Other: Incentive Item
28 Recruiting Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
Condition: Hunter Syndrome
Interventions: Biological: idursulfase-IT;   Other: No IT treatment
29 Completed
Has Results
An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients
Condition: Hunter Syndrome
Intervention: Biological: Idursulfase
30 Completed
Has Results
Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase
Conditions: Hunter Syndrome;   Mucopolysaccharidosis II (MPS II)
Intervention: Biological: Idursulfase
31 Active, not recruiting Extension of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase (IT)in Conjunction With Elaprase in Pediatric Patients With Hunter Syndrome and Cognitive Impairment
Condition: Hunter Syndrome
Intervention: Drug: Idursulfase-IT
32 Completed
Has Results
Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy
Conditions: Hunter Syndrome;   Mucopolysaccharidosis II;   MPS II
Intervention: Biological: Idursulfase
33 Completed Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)
Condition: Asthma
Intervention: Drug: Ciclesonide
34 Completed A Study of Administration of Trastuzumab (Herceptin) by a Single-use Injection Device Versus a Handheld Syringe
Condition: Healthy Volunteer
Intervention: Drug: trastuzumab [Herceptin]
35 Completed
Has Results
Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.
Condition: Skin Infections, Bacterial
Intervention: Drug: Retapamulin Ointment, 1%
36 Unknown  Improving the Self-Efficacy of African American Parents in Infant Supine Sleep
Condition: Infant Supine Sleep
Interventions: Other: Tailored educational materials;   Other: Standard sleep educational materials
37 Completed DTaP and Apnea/Bradycardia in Preterm Infants
Conditions: Prolonged Apnea;   Prolonged Bradycardia
Interventions: Biological: Infanrix;   Biological: Pediatrix
38 Completed Effects of Caffeine on Intermittent Hypoxia in Infants Born Preterm
Condition: Hypoxia
Intervention: Drug: Caffeine citrate 6 mg/kg/day
39 Completed Impact of Fluid Management Within a Goal-directed Hemodynamic Protocol on Acid-base Balance in Elective Trauma Surgery
Condition: Hemodynamic Instability
Intervention: Drug: Infusion Therapy
40 Completed Experimental Determination of Atot en Ka in the Critically Ill
Conditions: Sepsis;   CABG
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years